SCHEMBL6166123

SCHEMBL6166123

CC(C)Cc1nn(CCO)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.43
HTT P42858 3/20 0.39
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
BUB1 O43683 1/20 0.36
HDAC4 P56524 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
OPRM1 P35372 4/20 0.34
HSD17B10 Q99714 2/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
HSP90AA1 P07900 2/20 0.33
HSP90AB1 P08238 2/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165665 0.86 ALPL (0.39) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6162828 0.83 ALPL (0.63) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6163402 0.82 ALPL (0.45) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6164718 0.82 HTT (0.41) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6165525 0.80 HTT (0.61) HTTKMT2AHDAC1HDAC6OPRM1
SCHEMBL6164100 0.79 HDAC1 (0.45) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6167888 0.77 HTT (0.39) HTT
SCHEMBL6164113 0.76 OPRM1 (0.49) ALPLHTTKMT2AALDH1A1NPSR1
SCHEMBL6166859 0.76 HTT (0.39) HTT
SCHEMBL6162256 0.72 OPRM1 (0.50) HTTKMT2AALDH1A1NPSR1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed